REFERENCES
- McGorry P D. Preventive strategies in early psychosis: Verging on reality. British Journal of Psychiatry 1998; 172(Suppl. 33)1–2
- Porter R. The Greatest Benefit to Mankind. A Medical History of Humanity from Antiquity to the Present. HarperCollins, London 1997
- Shorter E. A History of Psychiatry. From the Era of the Asylum to the Age of Prozac. John Wiley and Sons, New York 1997
- MacKenzie C. Social Factors in the admission, discharge, and continuing stay of patients at Ticehurst Asylum, 1845–1917. The Anatomy of Madness: Essays in the History of Psychiatry, W F Bynum, R Porter, M Shepherd. Tavistock Publications, London 1985; Vol. II, Institutions and Society
- Laing R D. Sanity, Madness and the Family. Penguin books, Harmondsworth 1964
- Szasz T. The Myth of Mental Illness. Harper and Row, New York 1961
- New South Wales Department of Health. Enquiry Into Health Services for the Psychiatrically III and Developmentally Disabled. NSW Department of Health, Sydney 1983
- Bleuler M. A 23 year longitudinal study of 208 schizophrenics and impressions in regard to the nature of schizophrenia. The Transmission of Schizophrenia, D Rosenthal, S S Kety. Pergamon Press, New York 1968
- Ciompi L. Catamnestic long term study on the course of life and aging of schizophrenics. Schizophrenia Bulletin 1980; 6: 606–618
- Ram R, Bromet E J, Eaton W W, Pato C, Schwartz J E. The natural course of schizophrenia: A review of first-admission studies. Schizophrenia Bulletin 1992; 18: 185–207
- Falloon IRH, Coverdale J, Laidlaw T, et al, OTP Collaborative Group. Early intervention in schizophrenia disorders. British Journal of Psychiatry 1998; 172(Suppl. 33)33–38
- Kane J M. Drug therapy: Schizophrenia. New England Journal of Medicine 1996; 334: 34–41, In: Wood AJJ, ed.
- Davis J M. Overview: Maintenance therapy in psychiatry. 1. Schizophrenia. American Journal of Psychiatry 1975; 132: 1237–1245
- Marder S R, Van Kammen D P. Dopamine receptor antagonists. Comprehensive Textbook of Psychiatry, 6th edn., H I Kaplan, B I Sadock. Williams and Wilkins, Maryland 1995; 1999–2000
- Thomas C S, Lewis S. Which atypical antipsychotic?. British Journal of Psychiatry 1998; 172: 106–109
- McEvoy J P, Hogarty G E, Steinguard S. Optimal dose of neuroleptic in acute schizophrenia: a controlled study of the neuroleptic threshold and higher haloperidol dose. Archives of General Psychiatry 1991; 48: 739–745
- Waddington J L, Scully P J, O'Callaghan E. The new antipsychotics, and their potential for early intervention in schizophrenia. Schizophrenia Research 1997; 28: 207–222
- Lee M, Thompson P, Meltzer H. Effects of clozapine on cognitive function in schizophrenia. Journal of Clinical Psychiatry 1994; 55(Suppl. B)82–87
- Taylor P J, Special Hospitals' Treatment Resistant Schizophrenia Research Group. Schizophrenia, violence, clozapine and risperidone: A review. British Journal of Psychiatry 1996; 169(Suppl. 31)21–30
- Kane J M, Honigfeld G, Singer J, Meltzer H. Clozapine for the treatment-resistant schizophrenic: A double-blind comparison with chlorpromazine. Archives of General Psychiatry 1988; 45: 789–796
- Meyer A. Psychobiology: A Science of Man. Thomas, Illinois 1958
- Engel G. History, classification and current trends in psychosomatic medicine. Comprehensive Textbook of Psychiatry, 6th edn., H I Kaplan, B J Sadock. Williams and Wilkins, Maryland 1995
- Zubin J, Spring B. Vulnerability: A new view of schizophrenia. Journal of Abnormal Psychology 1977; 86: 103–126
- Nuechterlein K H, Dawson M E, Gitlin M, et al. Developmental processes in schizophrenic disorders. Longitudinal studies of vulnerability and stress. Schizophrenia Bulletin 1992; 18: 387–417
- Leff J, Kuipers L, Berkowitz R. A controlled trial of social intervention in the families of schizophrenic patients. British Journal of Psychiatry 1982; 141: 121–134
- Hogarty G E, Anderson C M, Reiss D J, et al. Family psychoeducation, social skills training, and maintenance chemotherapy in the after-care treatment of schizophrenia: One year effects of a controlled study on relapse and expressed emotion. Archives of General Psychiatry 1986; 43: 633–642
- Hogarty G E. Prevention of relapse in chronic schizophrenic patients. Journal of Clinical Psychiatry 1993; 54: 18–23
- Frese F J. Advocacy, recovery, and the challenges of consumerism for schizophrenia. Psychiatric Clinics of North America 1998; 21: 233–249
- Olfsen M. Assertive community treatment: An evaluation of the experimental evidence. Hospital and Community Psychiatry 1990; 41: 634–641
- Sommer R. Family advocacy and the mental health system. The recent rise of the Alliance for the Mentally III. Psychiatric Quarterly 1990; 61: 205–221
- Australian Health Ministers. Second National Mental Health Plan-National Mental Health Strategy. Mental Health Branch, Commonwealth Department of Health and Family Services, Canberra 1998
- Australian Health Ministers. First National Mental Health Strategy. Mental Health Branch, Commonwealth Department of Health and Family Services, Canberra 1992
- New South Wales Health Department. Caring for Mental Health. A Framework for Mental Health Care in NSW. NSW Department of Health, Sydney 1998
- New South Wales Health Department. NSW Strategy: Making Mental Health Better for Children and Adolescents. NSW Department of Health, Sydney 1999
- National Early Psychosis Project Clinical Guidelines Working Party. Australian Clinical Guidelines for Early Psychosis. National Early Psychosis Project, University of Melbourne, Melbourne 1996
- Centre for Mental Health. Getting In Early-A Framework for Progressing Early Intervention and Prevention in Mental Health for Young People in NSW. NSW Department of Health, Sydney 1999